40–50%
less effort per technical-file gap analysis
100%
of Annex II/GSPR requirements checked, not sampled
8 weeks
to a first agent in your validated environment
Agents across the technical file, the quality record and the post-market file — applying your SOPs and MDR/IVDR requirements to evidence you already hold, clause by clause.
What We Offer
Technical file gap check
Every Annex II and GSPR requirement mapped to the evidence that satisfies it, so the gaps surface before a notified body finds them. Nothing the agent is unsure about is closed silently.
ANNEX II · GSPR · GAP MAP
CAPA root-cause clustering
Deviations and CAPAs clustered to expose recurring causes and repeat closures across the whole quality record, not one file at a time.
DEVIATIONS · CAPA · ROOT CAUSE
Audit trail review
Scheduled audit trails reviewed at full coverage rather than by sample, with the review itself recorded as inspection evidence.
FULL COVERAGE · EVIDENCE LOG
Label and UDI consistency
Every market variant checked against the master label, Annex I §23 and QMSR 820.45, with each mismatch shown next to the rule it breaks.
ANNEX I §23 · QMSR 820.45
Post-market report assembly
PMS and PSUR content drafted from complaints, vigilance data and literature, with every figure traceable to the record behind it.
PMS · PSUR · VIGILANCE
What You Get
A gap register you can act on
Every Annex II and GSPR requirement listed against the evidence that meets it, with the clause and the owner attached.
Evidence that survives the audit
Each check leaves a log an assessor can follow, so the review effort becomes the inspection proof.
One review surface
QMS, design history file, complaints and artwork read together instead of file by file.
50–60%
less staff time per prior-authorisation package
~60% → 85%+
first-pass-complete intake
100%
of intake packs checked for consent version
Agents across intake, coverage and appeals — applying payer policy requirements to the clinical record and preparing the package a clinician signs. We work as the technology layer behind a hub or BPO.
What We Offer
Prior authorisation preparation
The evidence a specific payer policy requires, assembled and drafted for a clinician to approve. The policy citation sits next to every element, so the reviewer checks a claim rather than rebuilds one.
POLICY EVIDENCE · CLINICIAN SIGN-OFF
Appeal letter drafting
A policy-cited appeal built from the denial reason and the clinical record, ready for the same clinician to review and send.
DENIAL REASON · POLICY CITE
Eligibility and coverage check
Coverage verified and missing documents named before the claim goes out, rather than after the denial arrives.
COVERAGE · MISSING DOCS
Documentation completeness review
Encounter notes checked against coding and payer requirements at the point of capture, while the visit is still fresh.
NOTES · CODING · PAYER RULES
Denial pattern analysis
Where and why denials cluster, for teams that want the diagnosis before committing to a fix.
DENIALS · CLUSTERS · TRENDS
What You Get
Policy-complete submissions
Each package assembled against the specific payer policy, with the citation next to every element.
Fewer avoidable denials
Coverage gaps and missing documents named before the claim goes out, not after it comes back.
Clinician time back
Drafts arrive ready for review and signature rather than for reassembly.
50–60%
less effort per SKU dossier
100%
of claims traced to a substantiation source
100%
of ingredient entries screened across every market
Agents across safety dossiers, the claims matrix and market registrations — applying MoCRA, DSHEA and per-market ingredient rules to your formulation, label and study data, SKU by SKU.
What We Offer
Safety substantiation file assembly
The MoCRA product information file and supplement safety dossier built from what you already hold, with exactly which evidence is missing named per SKU rather than left for a reviewer to discover.
MoCRA · PIF · DSHEA · SAFETY EVIDENCE
Ingredient restriction screening
INCI entries and supplement ingredients screened across every target market, with prohibited entries and concentration breaches flagged against the limit that applies there.
INCI · LIMITS · MARKETS
Claims substantiation check
Each marketing and structure-function claim traced to the study behind it, with wording the evidence cannot carry flagged before artwork is locked.
CLAIMS · STUDIES · WORDING
Label and allergen verification
Ingredient lists, allergens, Supplement Facts panels and mandatory statements checked against the formula and the rules of each market you sell in.
ALLERGENS · SUPPLEMENT FACTS
Registration and listing maintenance
Facility registrations and product listings tracked against renewal dates and reformulation triggers, so nothing lapses quietly.
RENEWALS · REFORMULATION
What You Get
SKU-level safety files
MoCRA product information files and supplement dossiers built from what you already hold, with gaps named.
Claims you can defend
Every claim traced to the study behind it before artwork locks
Coverage across every market
Ingredient screening and label checks run per market, not per launch.
55–65%
less effort per monitoring and TMF cycle
100%
of filed artefacts scanned, against a 10–20% sample
Continuous
filing between milestones, not before inspection
Agents across monitoring, the trial master file, participant data, safety and submissions — applying your study rules and sponsor SOPs to records already captured, so teams move from manual execution to oversight.
What We Offer
Clinical research assistant
Site risks identified and prioritised proactively, with comprehensive pre-visit summaries and actionable recommendations that strengthen trial oversight and compliance.
RISK SIGNALS · PRE-VISIT · OVERSIGHT
Trial master file agent
Trial documents organised and filed continuously across studies, running between milestones rather than in a pre-inspection scramble.
FILING · CONTINUOUS · CROSS-STUDY
PI review agent
eCOA and participant data monitored and assembled for the principal investigator, so review and sign-off start from a prepared position.
eCOA · PARTICIPANT DATA · SIGN-OFF
Safety and pharmacovigilance agent
Case intake triaged, narratives drafted from the source records, and evidence routed to the right reviewer with the trail intact.
INTAKE · NARRATIVE · ROUTING
Regulatory and submission readiness
Submission components checked against the applicable requirements and assembled, with what is still outstanding named rather than discovered late.
COMPONENTS · CHECKS · ASSEMBLY
What You Get
Oversight, not execution
Monitoring, filing and assembly run continuously, so study teams review exceptions instead of working the queue.
Risk surfaced early
Site signals prioritised and summarised before the visit, while there is still time to act on them.
Evidence that holds up
Every narrative, filing and submission component traced to its source record and reviewer.
